IRADIMED CORP (IRMD) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 1012 transactions totaling $111.9M, demonstrating a bearish sentiment with -$110.6M in net insider flow. The most recent transaction on Dec 29, 2025 involved a sale of 101 shares valued at $9.9K.
No significant insider buying has been recorded for IRMD in the recent period.
No significant insider selling has been recorded for IRMD in the recent period.
Based on recent SEC filings, insider sentiment for IRMD is bearish with an Insider Alignment Score of 1/100 and a net flow of -$110.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IRADIMED CORP (IRMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading IRMD stock, having executed 1012 transactions in the past 90 days. The most active insider is Roger E. Susi (Executive), who has made 174 transactions totaling $65.5M.
Get notified when executives and directors at IRMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | E. Susi Roger | Executive | Sale | 101 | $98.31 | $9.9K | |
| Dec 29, 2025 | E. Susi Roger | Executive | Sale | 4,899 | $97.65 | $478.4K | |
| Dec 22, 2025 | E. Susi Roger | Executive | Sale | 3,772 | $96.42 | $363.7K | |
| Dec 22, 2025 | E. Susi Roger | Executive | Sale | 1,228 | $97.70 | $120.0K | |
| Dec 15, 2025 | E. Susi Roger | Executive | Sale | 731 | $97.13 | $71.0K | |
| Dec 15, 2025 | E. Susi Roger | Executive | Sale | 4,269 | $96.68 | $412.7K | |
| Dec 11, 2025 | K. Allen Monty | Executive | Option Exercise | 905 | $N/A | $0 | |
| Dec 11, 2025 | Glenn John | Executive | Option Exercise | 1,812 | $N/A | $0 | |
| Dec 11, 2025 | Glenn John | Executive | Sale | 532 | $98.09 | $52.2K | |
| Dec 11, 2025 | Glenn John | Executive | Sale | 14,468 | $97.26 | $1.4M | Large |
| Dec 11, 2025 | Glenn John | Executive | Payment | 714 | $97.38 | $69.5K | |
| Dec 11, 2025 | B. Hawkins James | Executive | Option Exercise | 905 | $N/A | $0 | |
| Dec 11, 2025 | Frederique Scharen-guivel Hilda | Executive | Option Exercise | 905 | $N/A | $0 | |
| Dec 11, 2025 | Chiprin Jeff | Executive | Option Exercise | 996 | $N/A | $0 | |
| Dec 11, 2025 | Chiprin Jeff | Executive | Payment | 309 | $97.38 | $30.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 567 | $111.2M | 94.7% |
Payment(F) | 73 | $2.8M | 2.4% |
Award(A) | 197 | $2.4M | 2.1% |
Purchase(P) | 8 | $648.8K | 0.6% |
Exercise(M) | 158 | $337.4K | 0.3% |
Gift(G) | 6 | $0 | 0.0% |
Conversion(C) | 3 | $0 | 0.0% |
Insider selling pressure at IRADIMED CORP has increased, with 16 insiders executing 1012 transactions across all time. Total sales of $111.2M significantly outpace purchases of $648.8K, resulting in a net outflow of $110.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.